These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 22176384)

  • 41. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stability of irritable bowel syndrome using a Rome II-based classification.
    Williams RE; Black CL; Kim HY; Andrews EB; Mangel AW; Buda JJ; Cook SF
    Aliment Pharmacol Ther; 2006 Jan; 23(1):197-205. PubMed ID: 16393298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polar vectors as a method for evaluating the effectiveness of irritable bowel syndrome treatments: an analysis with pinaverium bromide 100mg plus simethicone 300mg po bid.
    López-Alvarenga JC; Sobrino-Cossío S; Remes-Troche JM; Chiu-Ugalde J; Vargas-Romero JA; Schmulson M
    Rev Gastroenterol Mex; 2013; 78(1):21-7. PubMed ID: 23375823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subtypes of irritable bowel syndrome in children and adolescents.
    Self MM; Czyzewski DI; Chumpitazi BP; Weidler EM; Shulman RJ
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1468-73. PubMed ID: 24486406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
    Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subgroups of irritable bowel syndrome: a new approach.
    Walter SA; Skagerström E; Bodemar G
    Eur J Gastroenterol Hepatol; 2004 Oct; 16(10):991-4. PubMed ID: 15371922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.
    Heitkemper M; Cain KC; Shulman R; Burr R; Poppe A; Jarrett M
    Dig Dis Sci; 2011 Jul; 56(7):2050-8. PubMed ID: 21290181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.
    Drossman DA; Chey WD; Johanson JF; Fass R; Scott C; Panas R; Ueno R
    Aliment Pharmacol Ther; 2009 Feb; 29(3):329-41. PubMed ID: 19006537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bloating and distention in irritable bowel syndrome: the role of visceral sensation.
    Agrawal A; Houghton LA; Lea R; Morris J; Reilly B; Whorwell PJ
    Gastroenterology; 2008 Jun; 134(7):1882-9. PubMed ID: 18455167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between subtypes of irritable bowel syndrome and severity of symptoms associated with panic disorder.
    Sugaya N; Kaiya H; Kumano H; Nomura S
    Scand J Gastroenterol; 2008; 43(6):675-81. PubMed ID: 18569984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome.
    Camilleri M; Kim DY; McKinzie S; Kim HJ; Thomforde GM; Burton DD; Low PA; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):111-21. PubMed ID: 15017503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome.
    Zakko S; Barton G; Weber E; Dunger-Baldauf C; Rühl A
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1311-21. PubMed ID: 21507028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
    Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
    Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
    Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
    Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Osteopathy improves the severity of irritable bowel syndrome: a pilot randomized sham-controlled study.
    Florance BM; Frin G; Dainese R; Nébot-Vivinus MH; Marine Barjoan E; Marjoux S; Laurens JP; Payrouse JL; Hébuterne X; Piche T
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):944-9. PubMed ID: 22546751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community-based study.
    Yilmaz S; Dursun M; Ertem M; Canoruc F; Turhanoğlu A
    Int J Clin Pract; 2005 Mar; 59(3):361-9. PubMed ID: 15857337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome.
    Suttor VP; Prott GM; Hansen RD; Kellow JE; Malcolm A
    Dis Colon Rectum; 2010 Feb; 53(2):156-60. PubMed ID: 20087090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.